Ribavirin plus interferon versus interferon for chronic hepatitis C
Research output: Contribution to journal › Journal article › Research › peer-review
Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.
| Original language | English |
|---|---|
| Journal | Cochrane Database of Systematic Reviews |
| Issue number | 1 |
| Pages (from-to) | CD005445 |
| ISSN | 1361-6137 |
| DOIs | |
| Publication status | Published - 1 Jan 2010 |
ID: 34044493